Erdanib (Erdafitinib 5mg)

Erdanib 5mg is a highly effective generic version of Erdafitinib, a kinase inhibitor indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC) who have susceptible FGFR3 genetic alterations. It is prescribed for patients whose disease has progressed following at least one prior systemic therapy. Patient selection should be guided by an FDA-approved companion diagnostic for Erdafitinib.

Erdafitinib Dosage:

Before starting treatment with Erdafitinib, confirm the presence of FGFR3 genetic alterations in tumor specimens.

• Recommended initial dosage: 8 mg orally once daily, with a possible increase to 9 mg daily if certain criteria are met.

• Administration: Swallow the tablet whole, with or without food.

Erdafitinib Price in India:

The cost of Erdafitinib in online pharmacies in India is only 5% of its price in the United States.

Potential Serious Side Effects of Erdafitinib:

• Eye Problems: Eye issues, such as dry or inflamed eyes, corneal inflammation, and retinal disorders, are common with Erdafitinib and can be severe. Contact your healthcare provider immediately if you experience blurred vision, vision loss, or other visual changes. To help prevent dry eyes, use artificial tears, hydrating eye gels, or lubricating ointments every two hours while awake. Regular eye specialist visits will be arranged during treatment.

• High Phosphate Levels (Hyperphosphatemia): Elevated phosphate levels in the blood can be common but serious, potentially causing mineral buildup in body tissues. Your healthcare provider will monitor your phosphate levels 14 to 21 days after starting treatment, followed by monthly check-ups. You may require dietary changes, phosphate-lowering therapy, or adjustments to your Erdafitinib dosage.
  Contact your healthcare provider immediately if you develop painful skin lesions, muscle cramps, or numbness/tingling around your mouth.

Common Side Effects of Erdafitinib:

• Nail separation or poor nail formation

• Mouth sores

• Diarrhea

• Increased blood creatinine levels

• Elevated alkaline phosphatase levels

• Liver function changes

• Anemia (low red blood cell count)

• Low sodium levels

• Fatigue

• Dry mouth

• Dry skin

• Low phosphate levels

• Decreased appetite

• Altered sense of taste

• Constipation

• Increased calcium levels

• Dry eye

• Hand-foot syndrome (redness, swelling, peeling, tenderness on hands/feet)

• High potassium levels

• Hair loss

• Fluid buildup behind the retina

When to Contact Your Healthcare Provider:

Please inform your healthcare provider immediately if you experience:

• Nail issues such as separation, pain, bleeding, breakage, color/texture changes, or infections around the nail.

• Skin problems, including itchy rashes, dry/cracked skin, or signs of infection.

Fertility Considerations:

Erdafitinib may impact fertility in females who can become pregnant. Discuss any concerns with your healthcare provider.

Additional Information:

For more prescribing information, please request the "FDA Prescribing Information" from our customer service.